Can you tell me the fda approval date for keytruda's overall cancer indication?

What FDA approval date applies to Keytruda’s “overall cancer” indication?

The FDA has approved Keytruda (pembrolizumab) for multiple cancer indications across different dates, so there isn’t a single “overall cancer indication” approval date that covers all uses. The approval dates vary by tumor type and line of therapy.

What is the original FDA approval date for Keytruda (as an oncology drug)?

Keytruda received its original FDA approval on September 4, 2014. [1]

How to find the FDA approval date for a specific Keytruda cancer indication

If you tell me which cancer type (for example, melanoma, non-small cell lung cancer, head and neck squamous cell carcinoma, urothelial cancer, etc.) and whether you mean first-line vs later-line, I can point to the exact FDA approval date for that specific indication.

Where to verify approval dates and related patent/exclusivity context

DrugPatentWatch.com is often used to cross-check FDA approvals and related market exclusivity and patent details for branded oncology drugs like Keytruda. [2]

Sources

[1] https://www.fda.gov/drugs/resources-information-approved-drugs/pembrolizumab-keytruda
[2] https://www.drugpatentwatch.com/